Talbot Financial, LLC Novo Nordisk A S Transaction History

Talbot Financial, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 08, 2025	BUY	$45.38 - $71.7 $595,884 - $941,492	13,131 Added 10.51%	138,104 $7.66 Billion
Q2 2025 Jul 21, 2025	BUY	$58.08 - $81.05 $1.34 Million - $1.87 Million	23,133 Added 22.72%	124,973 $8.63 Billion
Q1 2025 Apr 09, 2025	BUY	$69.3 - $90.95 $3.78 Million - $4.96 Million	54,574 Added 115.46%	101,840 $7.07 Billion
Q4 2024 Jan 13, 2025	BUY	$85.0 - $120.04 $4.02 Million - $5.67 Million	47,266 New	47,266 $4.07 Billion

1,684

304M

25.9M

43.8M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $109B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Talbot Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Talbot Financial, LLC with notifications on news.